|
Volumn 118, Issue 2, 2014, Pages 368-375
|
The efficacy of the Peginterferon treatment in chronic hepatitis HDV and compensate liver cirrhosis.
a a a a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
ANTIVIRUS AGENT;
MACROGOL DERIVATIVE;
PEGINTERFERON ALPHA2A;
RECOMBINANT PROTEIN;
ADULT;
ARTICLE;
DELTA AGENT HEPATITIS;
FEMALE;
GENETICS;
HEPATITIS DELTA VIRUS;
HUMAN;
ISOLATION AND PURIFICATION;
LIVER CIRRHOSIS;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDY;
TREATMENT OUTCOME;
VIROLOGY;
ADULT;
ANTIVIRAL AGENTS;
FEMALE;
HEPATITIS D, CHRONIC;
HEPATITIS DELTA VIRUS;
HUMANS;
INTERFERON-ALPHA;
LIVER CIRRHOSIS;
MALE;
MIDDLE AGED;
POLYETHYLENE GLYCOLS;
PROSPECTIVE STUDIES;
RECOMBINANT PROTEINS;
TREATMENT OUTCOME;
|
EID: 84907676583
PISSN: 00487848
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|